These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11576704)

  • 21. Resectable non-small cell lung cancer Adjuvant chemotherapy: slightly longer survival.
    Prescrire Int; 2016 Dec; 25(177):299-301. PubMed ID: 30758927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials.
    Mouillet G; Monnet E; Milleron B; Puyraveau M; Quoix E; David P; Ducoloné A; Molinier O; Zalcman G; Depierre A; Westeel V;
    J Thorac Oncol; 2012 May; 7(5):841-9. PubMed ID: 22722786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancer.
    De Craene S; Surmont V; van Meerbeeck JP
    Curr Opin Oncol; 2010 Mar; 22(2):102-11. PubMed ID: 20180283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant and neoadjuvant therapy for early-stage non-small-cell lung cancer.
    Choong NW; Vokes EE
    Clin Lung Cancer; 2005 Dec; 7 Suppl 3():S98-104. PubMed ID: 16384544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consensus development conference on the medical treatment of non-small cell lung cancer: treatment of the early stages.
    Scagliotti G
    Lung Cancer; 2002 Dec; 38 Suppl 3():S23-9. PubMed ID: 12468140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.
    Roth JA; Fossella F; Komaki R; Ryan MB; Putnam JB; Lee JS; Dhingra H; De Caro L; Chasen M; McGavran M
    J Natl Cancer Inst; 1994 May; 86(9):673-80. PubMed ID: 8158698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical issues in the management of non-small-cell lung cancer and the role of platinum-based therapy.
    Socinski MA
    Clin Lung Cancer; 2004 Mar; 5(5):274-89. PubMed ID: 15086966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction or neoadjuvant therapy in resectable non-small cell lung cancer.
    Langer CJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):34-9. PubMed ID: 10566609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant therapy of resected non-small-cell lung cancer.
    Socinski MA
    Clin Lung Cancer; 2004 Nov; 6(3):162-9. PubMed ID: 15555217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early-stage NSCLC: the role of radiotherapy and systemic therapy.
    Bunn PA
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S31-40. PubMed ID: 19780244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II randomized trial of adjuvant chemotherapy with S-1 versus S-1 plus cisplatin for completely resected pathological stage II/IIIA non-small cell lung cancer.
    Okamoto T; Yano T; Shimokawa M; Takeo S; Yamazaki K; Sugio K; Takenoyama M; Nagashima A; Tsukamoto S; Hamatake M; Yokoyama H; Ueda H; Motohiro A; Tagawa T; Shoji F; Kometani T; Saito G; Fukuyama Y; Toyokawa G; Osoegawa A; Emi Y; Maehara Y;
    Lung Cancer; 2018 Oct; 124():255-259. PubMed ID: 30268470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neoadjuvant chemotherapy in non-small cell lung cancer: current state and future].
    Mellas N; Elmesbahi O; Masbah O; Errihani H
    Bull Cancer; 2010 Feb; 97(2):211-23. PubMed ID: 20051349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant chemotherapy in non-small cell lung cancer.
    Felip E; Rosell R
    Curr Med Chem; 2002 Apr; 9(8):893-8. PubMed ID: 11966451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant chemotherapy for resectable non-small-cell lung cancer.
    Gray J; Sommers E; Alvelo-Rivera M; Robinson L; Bepler G
    Oncology (Williston Park); 2009 Sep; 23(10):879-86. PubMed ID: 19839429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Docetaxel in neoadjuvant therapy of early-stage non-small cell carcinoma].
    Betticher DC
    Onkologie; 2003 Dec; 26 Suppl 7():33-6. PubMed ID: 14716140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gefitinib Versus Adjuvant Chemotherapy in Patients With Stage II-IIIA Non-Small-Cell Lung Cancer Harboring Positive EGFR Mutations: A Single-Center Retrospective Study.
    Xie H; Wang H; Xu L; Li M; Peng Y; Cai X; Feng Z; Ren W; Peng Z
    Clin Lung Cancer; 2018 Nov; 19(6):484-492. PubMed ID: 30369426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant chemotherapy in stage III NSCLC.
    Allen J; Jahanzeb M
    J Natl Compr Canc Netw; 2008 Mar; 6(3):285-93. PubMed ID: 18377847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy for non-small-cell lung carcinoma: from a blanket approach to individual therapy.
    Reungwetwattana T; Eadens MJ; Molina JR
    Semin Respir Crit Care Med; 2011 Feb; 32(1):78-93. PubMed ID: 21500127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant treatment of stage IB NSCLC: the problem of stage subset heterogeneity.
    Calhoun R; Jablons D; Lau D; Gandara DR
    Oncology (Williston Park); 2008 Apr; 22(5):511-6; discussion 516, 521-3. PubMed ID: 18533401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome.
    Romine PE; Martins RG; Eaton KD; Wood DE; Behnia F; Goulart BHL; Mulligan MS; Wallace SG; Kell E; Bauman JE; Patel SA; Vesselle HJ
    BMC Cancer; 2019 Jan; 19(1):70. PubMed ID: 30642285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.